HOX Genes Regulate Rac1 Activity in Hematopoietic Cells Through Control of Vav2 Expression
Total Page:16
File Type:pdf, Size:1020Kb
Letters to the Editor 236 HOX genes regulate Rac1 activity in hematopoietic cells through control of Vav2 expression Leukemia (2013) 27, 236–238; doi:10.1038/leu.2012.166 demonstrated to be an essential component of HOX-induced oncogenic pathways.8 There was a high concordance between the genes identified in our study (66% for upregulated and 72% for HOX homeobox transcription factors are not only master regu- downregulated targets) and those of Huang et al.4 Within the lators of segment identity but also instrumental for proper common HOXA1/Hoxa9 targets the known oncogene vav2 caught blood formation (reviewed in Argiropoulos and Humphries1 and our interest because Vav2 is a guanine-exchange factor for the Eklund2). The physiology of hematopoietic stem and progenitor small GTPase Rac1 and this factor has been implicated in MLL- cells (HSPC) is under the direct control of HOX proteins. In rearranged leukemia9,10 where MLL fusions work at least in part particular, members of the ‘HOX-A’ and ‘HOX-B’ paralog groups through upregulation of HOX genes. are predominantly expressed in HSPC. Differentiation requires a Vav2 RNA and Vav2 protein were quantified by quantitative downregulation of HOX genes and mature blood cells usually do reverse transcriptase-PCR and western blotting in HOXA1/ not express HOX proteins any more. An abnormal HOX activity Hoxa9-transformed cells cultivated with TAM and 72 h after TAM and, concomitantly, a block of differentiation are frequently deprivation (Figures 1a and b). Vav2 transcripts were reduced to observed in malignant hematopoiesis, thus qualifying HOX approximately 20% of initial levels and also Vav2 protein dropped members as bona fide oncogenes. significantly in TAM-free medium. The genomic area upstream of Despite their importance in hematopoiesis, little is known about the vav2 transcription initiation site contains several potential the HOX-subordinate pathways that are crucial for HSPC biology Pbx/Hox- and Meis/Hox-binding sites between À 1 and À 3kb and leukemogenesis. A few studies have been published trying to (Figure 1c). ChIP analysis was performed with primer pairs flank- identify HOX target genes in hematopoietic cells.3–5 One recurrent ing these regions. An additional primer was placed into an problem is the multitude of genes that are under control of the X-chromosome satellite sequence as negative control. Significant HOX ‘master regulators’. It is difficult to discriminate the ‘driver’ enrichment of HOXA1-ER and Hoxa9-ER was detected at all genes with importance in hematopoiesis from ‘bystanders’ that potential binding sites. Owing to the technical resolution of the may be true HOX targets but have less impact on HSPC ChIP analysis (fragment size B500–800 bp), the primer pair development. In this study we tried to address this problem by at À 2 kb could also detect the occupation of neighboring Pbx/ identifying a common gene expression pattern shared between HOX sites. Indeed the highest HOX enrichment scores were HOXA1 and Hoxa9, two unrelated, yet both transforming HOX obtained for the region at À 2 kb. Anti-ER-specific antibodies proteins.6 precipitated up to 10-fold more DNA in HOXA1-ER-transformed As shown previously,6 the labial-type HOXA1, as well as the cells compared with the control experiments. In Hoxa9-ER abdominal-like HOXA9, transforms primary hematopoietic proge- populations a 20-fold enrichment of this genomic region was nitors into immortalized myeloblasts. Therefore we reasoned that detected, arguing strongly for a direct regulation of vav2 by HOX/ genes essential for myeloid transformation should be triggered by Pbx and/or HOX/Meis. both HOX proteins in a similar fashion and hence these genes Next we checked if the corresponding sequences confer HOX should be enriched within the common targets. To investigate this responsiveness to a heterologous gene. For that purpose the hypothesis we used tamoxifen (TAM)-inducible derivatives of putative vav2 promoter from position À 3081 to þ 1 relative to HOXA1 and Hoxa9 created by fusion of a modified estrogen– the transcription start was cloned into a luciferase reporter (pGL3). ligand binding domain (ER) as reported previously.6 (Hoxa9 shares The construct was introduced into the embryonal carcinoma cell 97% homology with human HOXA9; therefore we decided to use line P19 because these cells, in contrast to many other cell lines, an existent murine clone.) As expected, transduction7 of progeni- have been demonstrated to be permissive for HOX-mediated tor cells with both HOX derivatives leads to the immortalization transactivation.11 Expression plasmids for HOXA1, Hoxa9 and the of cytokine-dependent, myeloblastic populations that could be HOX cofactors Meis1 and Pbx1 were cotransfected individually or cultivated in medium supplemented with 100 ng/ml SCF, 10 ng/ml in combinations. Consistent with a promoter under HOX control, each of IL-3, IL-6, GM-CSF, and 100 nM 4-hydroxy-TAM. Importantly, the transfection of each HOX protein and/or cofactor had an these cells did not apoptose in the absence of TAM, but initiated a independent and cumulative effect on promoter output normal program of differentiation, terminating with the appearance (Figure 1d). Although total transactivation rates were moderate, of mature granulocytes and macrophages within approximately they were significant and in the range of what had been obtained 1 week (data not shown). Four individual cell lines were created in similar experiments with other HOX-dependent promoter/ for each HOX construct from different donor animals. RNA was enhancer elements.4,5 Therefore these results are consistent with a isolated with TAM present and 72 h after TAM withdrawal. This direct regulation of vav2 by HOXA1 and Hoxa9. schedule was chosen because first significant changes in Subsequently we tested if also Rac1 activity is controlled by expression of several differentiation genes became detectable at HOX activity. Active Rac-GTP can be specifically precipitated by a that time point. Comparison of the expression profiles (raw data GST-fusion with the Rac downstream partner PAK (p21 protein - deposited at ArrayExpress under accession number E-MEXP-3648) Cdc42/Rac-activated kinase) as described in Giehl et al.12 and revealed 948 and 374 genes that were significantly (change Figure 2a. Lysates of HOXA1-ER and Hoxa9-ER cells were prepared 41.7-fold, Po0.1) upregulated by HOXA1 and Hoxa9, respec- from cultures in TAM and 72 h after transfer to TAM-free media. tively. A similar number of transcripts with opposite behavior After incubation with GST-PAK and thorough washing, the bound could be detected (731 and 441 genes increased expression material was analyzed by a Rac1-specific immunoblot alongside after HOX inactivation in HOXA1 and Hoxa9 cells). Among all input controls (Figure 2b). Whereas total Rac1 levels did not HOX-responsive transcripts, a core group of 61 upregulated and change significantly, Rac1-GTP amounts were clearly correlated to 57 downregulated genes was shared by HOXA1 and Hoxa9. This HOX activity. Although HOXA1-ER-transformed cells contained included the myeloblastosis oncogene c-Myb that had been lower concentrations of active Rac1-GTP than their Hoxa9-ER Accepted article preview online 20 June 2012; advance online publication, 13 July 2012 Leukemia (2013) 233 – 258 & 2013 Macmillan Publishers Limited Letters to the Editor 237 Figure 1. HOX-dependent regulation of vav2.(a) Quantitative reverse transcriptase PCR measuring vav2 transcripts in RNA isolated from HOXA1-ER and Hoxa9-ER-transformed cells in the presence and 72 h after removal of TAM as indicated. Expression in fully induced HOX- Figure 2. Rac1 activity is HOX-dependent and is controlled by Vav2. transformed cells was set arbitrarily to one unit. Average values and (a) Schematic principle of Rac assay. A GST fusion with a Rac s.d.s of PCR triplicates are indicated by error bars. (b) Western blot downstream mediator, the PAK protein, permits specific precipita- analysis detecting Vav2 protein levels in total cellular extracts of the tion of Rac-GTP. (b) Rac1 activity in HOXA1-ER- and Hoxa9-ER- cells as given in (a). Blotting was done with an anti-mouse Vav2 transformed cells in the presence and 72 h after removal of TAM. antibody. Actin served as loading control. In Hoxa9-ER cells a Cellular extracts were incubated with GST-PAK and bound Rac1-GTP truncated version of Vav2 is labeled with an asterisk. (c) Enrichment was analyzed by Rac1-specific immunoblotting alongside with of HOX proteins in the vav2 upstream region was detected by ChIP. respective input samples. The figure shows a typical example out Crosslinked chromatin from HOXA1-ER and Hoxa9-ER cells was of two replicates. (c) Typical example of a replating assay performed precipitated by an anti-ER antibody and analyzed by quantitative either with wild-type or vav2 knock-out bone marrow progenitor PCR employing primers spanning the HOX/Meis consensus sites in cells. The cells were transduced with HOXA9 and replated in the putative vav2 promoter. The structure of the vav2 upstream methocel.7 No significant difference in colony formation was seen in region including the location and sequence of the potential HOX/ four independent experiments. The lower panel shows a Vav2- Meis and HOX/Pbx sites is depicted in the top panel. Anti-mouse IgG specific western blot done on extracts from HOXA9-transformed and a primer pair (primer X) amplifying a X-chromosomal satellite wild-type, vav2 À / À , and knock-out cells complemented with VAV2, sequence were used as a negative controls. Given are relative as indicated. (d) Upper panel: Rac activity in wild-type and vav2 À / À enrichment levels above IgG control divided by background cells. Rac-GTP levels were determined analogous to (b) in cellular enrichment at the X-satellite as mean and s.d. of triplicates. extracts of HOXA9-transformed cells from wild-type or knockout (d) Reporter gene analysis of HOX-dependent promoter activity.